---
title: Clearsynth vs Micromacinazione
slug_a: clearsynth
slug_b: micromacinazione
site: cdmo
review_signal_gate: closed
canonical_path: /compare/clearsynth/micromacinazione
---

# Clearsynth vs Micromacinazione

Side-by-side profile data from each company listing on this directory.

## Clearsynth

- Profile: [/companies/clearsynth](/companies/clearsynth)

Clearsynth — Clearsynth delivers advanced deuterium science, isotopically labelled compounds, custom synthesis, and specialized CDMO services for small-molecule drug discovery and development. ISO 17025, ISO 17034, and ISO 9001:2015 certified with capabilities spanning reference standards, generic APIs, process development, and scale-up manufacturing.

Services: 5. Modalities: 1. Indications: 0. Locations: 3. Certifications: 4. The strongest documented coverage currently appears in services (5).

### Services

- Small Molecule Development & Manufacturing
- API Synthesis & Manufacturing
- Process Development
- CMC Analytical Development
- Quality Control Testing

### Modalities

- Small Molecule

### Development capabilities

- Analytical method development

### Manufacturing capabilities

- Drug Substance (DS)
- Max chemical: Pilot (10 kg – 100 kg)
- DEA licensed

## Micromacinazione

- Profile: [/companies/micromacinazione](/companies/micromacinazione)

Micromacinazione — Swiss-based CDMO specializing in particle engineering and micronization with over 50 years of experience. Offers micronization, milling, spray drying, solid-state characterization, and complementary processing services (classification, blending, cryogenic, co-micronization, conditioning) for APIs, HPAPIs, controlled substances, and excipients from early development to commercial GMP scale.

Services: 6. Modalities: 1. Indications: 0. Locations: 2. Certifications: 1. The strongest documented coverage currently appears in services (6).

### Services

- Small Molecule Development & Manufacturing
- API Synthesis & Manufacturing
- HPAPI Manufacturing (High-Potency)
- Solid-State Chemistry & Polymorph Screening
- Process Development
- CMC Analytical Development

### Modalities

- Small Molecule

### Development capabilities

- Analytical method development
- Formulation development
- Solid-state characterization

### Manufacturing capabilities

- Drug Substance (DS)
- Max chemical: Commercial (>100 kg / tonne)
- HPAPI
- DEA licensed
- Cryogenic (−80 °C)